Tech
In reversal, American Cancer Society urges prostate cancer tests for all men
Publication: Ars Technica
Author: Beth Mole
Source published: 12/11/2026, 22:59:51 UTC
Briefing created: 12/11/2026, 23:15:56 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 12/11/2026, 23:13:24 UTC.
Briefings
The American Cancer Society updated its prostate cancer screening guidelines, recommending routine PSA testing for all men aged 50 to 69 every two years, with earlier initiation at age 45 for high-risk groups. Black men and those with close relatives diagnosed under age 65 are advised yearly testing starting at 45, while single relatives diagnosed at age 65 or older allow a two-year interval for non-Black men. Coverage is limited to the 2026-11-12 release, and specific impact on mortality rates remains unverified.
Key points
- The American Cancer Society recommends routine PSA testing every two years for men aged 50 to 69 at average risk.
- Black men and those with close relatives diagnosed under age 65 should undergo yearly testing starting at age 45.
Context
This update shifts screening recommendations from age 50 to 45 for high-risk populations, reflecting a 2026 shift in prostate cancer screening guidelines.
Limitations
Coverage limited to the 2026-11-12 release; specific impact on mortality rates remains unverified.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 12/11/2026, 23:15:56 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeihxpo7gjs7aoo2gb3ganc67gxe4x2hd7vvhgegimnxqyhahjoyn6m